Examples of GSK Bio in a sentence
The right to name the Chairperson shall alternate between the Committee Parties with GSK Bio designating the first such Chairperson.
During the Inhaled Option Period and/or Vaccines Option Period, Liquidia shall have the right to grant a non-exclusive license to its interests in the Joint Inhaled Collaboration Know-How or Joint Vaccines Collaboration Know-How as described in Section 11.4(b)(iii) for use in the consumer healthcare field or diagnostic field; provided, that it shall first notify GSK and GSK Bio of such desire in writing, describing in reasonable detail the scope of the license it is interested in granting to a Third Party.
Within fifteen (15) days after the Effective Date, the Parties shall, together with GSK Bio (collectively referred to as the “Committee Parties”), establish a joint steering committee (the “Joint Steering Committee” or “JSC”) to oversee the Collaboration Program.
GSK or GSK Bio shall have thirty (30) days from the receipt of the ROFN Notice to inform Liquidia in writing of its election to negotiate the terms of such exclusive license, and another thirty (30) days to submit to Liquidia an initial proposal for the terms of such exclusive license.
The JSC shall consist of two (2) representatives of each of GSK and GSK Bio, and four (4) representatives of Liquidia, in each case that have sufficient seniority to make decisions arising within the scope of the JSC’s responsibilities.
If GSK or GSK Bio delivers such notice during the first thirty (30) day period and submits the initial proposal within the second thirty (30) day period, Liquidia shall negotiate exclusively in good faith with GSK or GSK Bio, for a period not to exceed six (6) months from GSK’s or GSK Bio’s receipt of the ROFN Notice (the “Negotiation Period”), the terms under which Liquidia will grant such exclusive license to GSK or GSK Bio.
Further, each time Liquidia desires to grant a non-exclusive license to the Joint Inhaled Collaboration Know-How or Joint Vaccines Collaboration Know-How in a different field than previously proposed to GSK in the right of first negotiation described in this Section 4.3, either to the same Third Party or a different Third Party, then such additional license in a different field shall first be offered to GSK or GSK Bio on the terms set forth above.
Appendix 1: Corixa Documents Provided as Controlled Documents to GSK Bio Appendix 2: [*] Appendix 3: [*] Appendix 4: Change Notification Form Appendix 5: [*] Appendix 6: Supply Agreement Responsibilities *CONFIDENTIAL TREATMENT REQUESTED.
GSK Corporation d/b/a/ GlaxoSmithKline Biologicals N.A. By: /s/ Xxxx Xxxxxxxxxxxx By: /s/ Jean Stephenne Name: Xxxx Xxxxxxxxxxxx Name: Jean Stephenne Title: Chief Operating Officer Title: CEO, GSK Bio Date: August 29, 2008 Date: September 2, 0000 XXXXXXXX 3 — Firm Forecast Mechanism (Example) Issued Quarterly 1st year 100% binding (no variation allowed) 2nd year 50% binding (max.